Anne‐Lise Ménard

745 total citations
15 papers, 187 citations indexed

About

Anne‐Lise Ménard is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Pathology and Forensic Medicine. According to data from OpenAlex, Anne‐Lise Ménard has authored 15 papers receiving a total of 187 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 4 papers in Public Health, Environmental and Occupational Health and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Anne‐Lise Ménard's work include Hematopoietic Stem Cell Transplantation (10 papers), Acute Lymphoblastic Leukemia research (4 papers) and Acute Myeloid Leukemia Research (3 papers). Anne‐Lise Ménard is often cited by papers focused on Hematopoietic Stem Cell Transplantation (10 papers), Acute Lymphoblastic Leukemia research (4 papers) and Acute Myeloid Leukemia Research (3 papers). Anne‐Lise Ménard collaborates with scholars based in France, Lebanon and United States. Anne‐Lise Ménard's co-authors include Hervé Tilly, Fabrice Jardin, Élodie Bohers, Christian Bastard, Marion Alcantara, Catherine Maingonnat, Pascaline Etancelin, Philippe Ruminy, Vinciane Marchand and Sylvain Mareschal and has published in prestigious journals such as SHILAP Revista de lepidopterología, British Journal of Haematology and Genes Chromosomes and Cancer.

In The Last Decade

Anne‐Lise Ménard

13 papers receiving 186 citations

Peers

Anne‐Lise Ménard

HEMAT

PFM

ONCOL

GENET

PHEOH

Kiyomi Morita United States

Kalman Filanovsky Israel

Silvia Imbergamo Italy

Fatima Zahra Jelloul United States

Jiejing Qian China

Bernard De Prijck Belgium

Esperanza Lavilla Spain

Fernando Roncolato Australia

Pallavi Galera United States

A. Birgitta Versluijs Netherlands

Kiyomi Morita United States

Anne‐Lise Ménard

140 ×1.3

HEMAT

39 ×0.7

PFM

76 ×1.3

ONCOL

55 ×1.3

GENET

90 ×2.5

PHEOH

Citations per year, relative to Anne‐Lise Ménard Anne‐Lise Ménard (= 1×) peers Kiyomi Morita

Countries citing papers authored by Anne‐Lise Ménard

Since Specialization

Citations

This map shows the geographic impact of Anne‐Lise Ménard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne‐Lise Ménard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne‐Lise Ménard more than expected).

Fields of papers citing papers by Anne‐Lise Ménard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne‐Lise Ménard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne‐Lise Ménard. The network helps show where Anne‐Lise Ménard may publish in the future.

Co-authorship network of co-authors of Anne‐Lise Ménard

This figure shows the co-authorship network connecting the top 25 collaborators of Anne‐Lise Ménard. A scholar is included among the top collaborators of Anne‐Lise Ménard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne‐Lise Ménard. Anne‐Lise Ménard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Michonneau, David, Florent Malard, Léonardo Magro, et al.. (2025). Efficacy and safety of belumosudil for treatment of cGVHD: multicenter retrospective analysis of the French cohort of the compassionate use program, on behalf of the French Society of Bone Marrow Transplantation and Cellular Therapy. Bone Marrow Transplantation. 60(6). 779–786. 4 indexed citations

Brissot, Éolia, Myriam Labopin, Hélène Labussière, et al.. (2024). Post-transplant cyclophosphamide versus anti-thymocyte globulin after reduced intensity peripheral blood allogeneic cell transplantation in recipients of matched sibling or 10/10 HLA matched unrelated donors: final analysis of a randomized, open-label, multicenter, phase 2 trial. Blood Cancer Journal. 14(1). 31–31. 12 indexed citations

Conrad, Anne, Yves Béguin, Amandine Le Bourgeois, et al.. (2023). Mise à jour du calendrier vaccinal après allogreffe de cellules souches hématopoïétiques : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC). Bulletin du Cancer. 111(2). S40–S49.

Xhaard, Aliénor, Constance Xhaard, Marie‐Thérèse Rubio, et al.. (2023). A 16‐month‐long experience of COVID‐19 in allogeneic haematopoietic stem cell transplantation recipients: An SFGM‐TC multicentre cohort study. British Journal of Haematology. 201(6). 1066–1071. 3 indexed citations

Alani, Mustafa, Nathalie Contentin, Anne‐Lise Ménard, et al.. (2022). Successful treatment of severe post hematopoietic stem cell transplantation bronchiolitis obliterans syndrome with lung transplantation in a patient with multi‐organ chronic graft‐versus‐host disease. SHILAP Revista de lepidopterología. 10(9).

Perdrix, Anne, Pascaline Etancelin, Anne‐Lise Ménard, et al.. (2022). Cardiovascular outcomes of patients treated for non-Hodgkin lymphoma with first-line doxorubicin-based chemotherapy. Leukemia & lymphoma. 63(14). 3340–3350. 4 indexed citations

Lequesne, Justine, Pascal Lenain, Nathalie Contentin, et al.. (2021). Outcomes after intensive care unit admission in newly diagnosed diffuse large B‐cell lymphoma patients: A real‐life study. European Journal Of Haematology. 106(6). 788–799. 2 indexed citations

Clavier, Thomas, et al.. (2019). Rescue stem cell allograft in intensive care unit patients during septic shock with multi-organ failure. Journal of Critical Care. 54. 122–124. 2 indexed citations

Detrait, Marie Y., Eva de Berranger, Rémy Duléry, et al.. (2019). Complications hépatobiliaires dans le contexte de l’allogreffe de cellules hématopoïétiques : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC). Bulletin du Cancer. 107(1). S18–S27. 1 indexed citations

10.

Vos, John De, Étienne Baudoux, Jacques‐Olivier Bay, et al.. (2018). Injections de lymphocytes du donneur (DLI) : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC). Bulletin du Cancer. 106(1). S35–S39. 11 indexed citations

11.

Duléry, Rémy, Anne‐Lise Ménard, Sylvain Chantepie, et al.. (2018). Sequential Conditioning with Thiotepa in T Cell- Replete Hematopoietic Stem Cell Transplantation for the Treatment of Refractory Hematologic Malignancies: Comparison with Matched Related, Haplo-Mismatched, and Unrelated Donors. Biology of Blood and Marrow Transplantation. 24(5). 1013–1021. 54 indexed citations

12.

Gargala, Gilles, Vincent Camus, Aspasia Stamatoullas, et al.. (2018). Cyberlindnera jadinii (teleomorph Candida utilis) candidaemia in a patient with aplastic anaemia: a case report. JMM Case Reports. 5(8). e005160–e005160. 8 indexed citations

13.

Beckerich, Florence, Claude‐Eric Bulabois, Patrice Chevallier, et al.. (2017). Stratégies préventives et thérapeutiques de la rechute après allogreffe de cellules souches hématopoïétiques : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC). Bulletin du Cancer. 104(12). S84–S98. 9 indexed citations

14.

Paviglianiti, Annalisa, Annalisa Ruggeri, Fernanda Volt, et al.. (2017). Evaluation of a disease risk index for adult patients undergoing umbilical cord blood transplantation for haematological malignancies. British Journal of Haematology. 179(5). 790–801. 10 indexed citations

15.

Bohers, Élodie, Sylvain Mareschal, Vinciane Marchand, et al.. (2013). Targetable activating mutations are very frequent in GCB and ABC diffuse large B‐cell lymphoma. Genes Chromosomes and Cancer. 53(2). 144–153. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact